Comparative evaluation of antioxidant and antiatherogenic effects of naturally occuring compounds and synthetic organic compounds of selenium

Biomeditsinskaya Khimiya

Volumn 49, Issue 2, 2003, Pages 201-207

  Khachaturova, V R ^a   Suprun, I V ^b   Vasiljev, A V ^a  

^a FEDERAL RESEARCH CENTRE OF NUTRITION   (Russian Federation)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Antioxidants; Atherogenecity; Cells of human aortic subendothelial intima; Macrophage

Indexed keywords

ANTIATHEROGENIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; ISOFLAVONE DERIVATIVE; SELENIUM DERIVATIVE; UNCLASSIFIED DRUG; ORGANOSELENIUM DERIVATIVE;

ANTIATHEROGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; DRUG SCREENING; HUMAN; HUMAN CELL; MACROPHAGE; SUBENDOTHELIUM; ARTERIOSCLEROSIS; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; ARTERIOSCLEROSIS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; ISOFLAVONES; MACROPHAGES; ORGANOSELENIUM COMPOUNDS;

EID: 0346362170     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Vladimirov Y.A. (1986). Free Radicals, Aging and Degenerative Diseases. N.Y., London, Alan R. Liss Inc., pp.141-195
2. Visioli F., Galli C. (1997) Nutr. Metab. Cardiovasc. Dis., No7, 459-466.
3. Brown L.A.S., Jones D.P. (1996) In: Handbook of Antioxidants, N.Y. - Basel-Hong Kong, pp. 117-154.
4. Rice-Evans C.A., Diplock A.T. (1993) Free Radic. Biol. Med., 15, 77-96.
5. Orekhov A.N., Tertov V.V., Novikov I.D. et al. (1985). Exp. Mol. Pathol., 41, 117-137
6. Lowry O.H., Rosebrough N.I., Farr A.L. et al. (1951) J.Biol.Chem., 193, 265-275
7. Yagi K. (1984). Methods Enzymol., 105, 328-333
8. Brown M.S., Goldstein I.L. (1983). Ann. Rev. Biochem, 52, 223-229